Spero Therapeutics(DE:2HA)
€0.900.00 (0.00%)
DE:2HA
Spero Therapeutics earnings date
€0.90
At close:0.00 (0.00%)
Spero Therapeutics (2HA) Q3 2023 Earnings Report
2 Followers
DE:2HA Q3 2023 EPS Results
- Actual EPS
- -EUR 0.05
- Consensus EPS
- -EUR 0.03
- Beat/Miss
- Missed by -EUR 0.03
- One Year Ago EPS
- -EUR 0.30
DE:2HA Q3 2023 Revenue Results
- Actual Revenue
- EUR 21.21M
- Expected Revenue
- EUR 13.58M
- Beat/Miss
- Beat by +EUR 7.63M
- YoY Revenue Growth
- +2061.00%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/13/2023
- Time
- After Close
- Conference Call
- Monday, November 13, 2023
DE:2HA Upcoming Earnings
Spero Therapeutics's next earnings date is estimated for April 1, 2027, based on past reporting schedules.
Q3 2023 Earnings Call Audio
DE:2HA Q3 2023 Earnings Call
0:00 / 0:00
Q3 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2HA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 01, 2027 | 2026 (Q4) | -0.17- | -0.12 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.43-0.69 | -0.12 | -484.62% (-0.57) | |
| Aug 12, 2026 | 2026 (Q2) | ―-0.15 | -0.03 | -433.33% (-0.12) | |
| May 13, 2026 | 2026 (Q1) | ―-0.12 | -0.23 | 48.00% (+0.11) | |
| Mar 26, 2026 | 2025 (Q4) | -0.180.48 | -0.34 | 239.47% (+0.83) | |
| Nov 13, 2025 | 2025 (Q3) | -0.23-0.12 | -0.29 | 59.38% (+0.17) | |
| Aug 12, 2025 | 2025 (Q2) | -0.34-0.03 | -0.3 | 90.91% (+0.27) | |
| May 13, 2025 | 2025 (Q1) | -0.50-0.23 | -0.22 | -4.17% (-0.01) | |
| Mar 27, 2025 | 2024 (Q4) | -0.28-0.34 | 0.87 | -139.58% (-1.22) | |
| Nov 14, 2024 | 2024 (Q3) | -0.24-0.29 | -0.05 | -433.33% (-0.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
